Want to see HK:8307 full AI Analyst Report?
8307 Stock Chart & Stats
HK$0.17
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$0.17
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.02 - HK$0.24
Previous CloseN/A
Volume16.00K
Average Volume (3M)24.27K
Market Cap
HK$48.80M
Enterprise ValueHK$42.34M
Total Cash (Recent Filing)HK$29.46M
Total Debt (Recent Filing)HK$17.57M
Price to Earnings (P/E)1180.0
Beta0.28
Next Earnings
Nov 16, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding396,736,000
10 Day Avg. Volume55,600
30 Day Avg. Volume24,266
Financial Highlights & Ratios
PEG Ratio-0.49
Price to Book (P/B)11.39
Price to Sales (P/S)1.24
P/FCF Ratio13.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Consistent Free Cash FlowConsistent positive operating and free cash flow provides a durable internal funding source. This sustains working capital, supports debt servicing and selective investment even with profit volatility, reducing reliance on external financing and improving resilience over months.
Sustained EBITDA MarginsMid‑teens EBITDA margins across multiple years show the core business generates healthy operating cash earnings. Durable underlying margins help absorb SG&A and one‑offs, underpin cash conversion and create a more stable base for restoring net profitability over the medium term.
Return To ProfitabilityReturning to a small net profit in FY2026, alongside positive multi‑year revenue growth, signals operational recovery and management traction. A sustained shift from losses to recurring profit improves long‑term viability provided margins and cash generation remain supportive.
Bears Say
Elevated LeverageVery high debt relative to equity and a small equity base materially reduce financial flexibility. Elevated leverage increases refinancing and interest exposure, limits capacity for investment or cushioning operational setbacks, and raises solvency risk if cash flows weaken.
Revenue VolatilityMeaningful swings and a recent sharp revenue decline undermine predictability of cash flow and budgeting. Top‑line volatility complicates cost planning, heightens execution risk, and weakens visibility into sustainable demand and pricing power over the coming months.
Gross Margin CompressionA substantial fall in gross margin suggests cost pressure or adverse revenue mix that erodes earnings quality. Persistent margin compression reduces operating leverage, shrinks free cash flow and constrains the company’s ability to deleverage or reinvest for growth over the medium term.
8307 FAQ
What was Medicskin Holdings Ltd.’s price range in the past 12 months?
Medicskin Holdings Ltd. lowest stock price was HK$0.02 and its highest was HK$0.24 in the past 12 months.
What is Medicskin Holdings Ltd.’s market cap?
Medicskin Holdings Ltd.’s market cap is HK$48.80M.
When is Medicskin Holdings Ltd.’s upcoming earnings report date?
Medicskin Holdings Ltd.’s upcoming earnings report date is Nov 16, 2026 which is in 106 days.
How were Medicskin Holdings Ltd.’s earnings last quarter?
Medicskin Holdings Ltd. released its earnings results on Jun 22, 2026. The company reported HK$0.002 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.002.
Is Medicskin Holdings Ltd. overvalued?
According to Wall Street analysts Medicskin Holdings Ltd.’s price is currently Overvalued.
Does Medicskin Holdings Ltd. pay dividends?
Medicskin Holdings Ltd. pays a Notavailable dividend of HK$0.025 which represents an annual dividend yield of N/A. See more information on Medicskin Holdings Ltd. dividends here
What is Medicskin Holdings Ltd.’s EPS estimate?
Medicskin Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medicskin Holdings Ltd. have?
Medicskin Holdings Ltd. has 396,736,000 shares outstanding.
What happened to Medicskin Holdings Ltd.’s price movement after its last earnings report?
Medicskin Holdings Ltd. reported an EPS of HK$0.002 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 22.549%.
Which hedge fund is a major shareholder of Medicskin Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:8307
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Medicskin Holdings Ltd.
Medicskin Holdings Limited, an investment holding company, provides medical skin care services in Hong Kong. The company operates Medicskin centers, which provides various medical skin care services for the treatment of skin diseases and problems, such as acne, pigmentation, rosacea, dermatitis, eczema, and warts, as well as improvement of appearance through inter alia, skin rejuvenation, facial sculpturing, and body contouring treatments; and treatment of acne scars and enlarged pores, removal of undesirable naevi, and hair removal. It provides medical consultancy services. In addition, the company engages in the sale of skincare products and medical skincare services. Further, it provides prevention healthcare services; body care and men care services, as well as offer mediskin vaccination. Medicskin Holdings Limited was founded in 2000 and is headquartered in Sheung Wan, Hong Kong. The company is a subsidiary of Topline Worldwide Limited.
Technical Analysis
EuroEyes International Eye Clinic Limited
―
Raily Aesthetic Medicine International Holdings Limited
―
Beauty Farm Medical & Health Industry, Inc.
―
Arrail Group Ltd.
―
Saint Bella Inc.
―